Search
- Browse Authors in the U.C. Berkeley Division of Biostatistics Working Paper Series
Notification
Most popular papers
COBRA Notification
Most Popular Papers
Institutions: Join COBRA
About COBRA
- Application of Time-to-Event Methods in the Assessment of Safety in Clinical Trials
-
-
Download the Paper
Forward to a colleague
- Article comments:
- Published in 2009 in Application of Time-to-Event Methods in the Assessment of Safety in Clinical Trials. (Chapter 20; 455-482); In Design and Analysis of Clinical Trials with Time-to-Event Endpoints [Peace, KE (Ed.)]; Chapman & Hall/ CRC Biostatistics Series.
- Abstract:
- Since randomized controlled trials (RCT) are typically designed and
powered for efficacy rather than safety, power is an important concern
in the analysis of the effect of treatment on the occurrence of
adverse events (AE). These outcomes are often time-to-event outcomes
which will naturally be subject to right-censoring due to early
patient withdrawals. In the analysis of the treatment effect on such
an outcome, gains in efficiency, and thus power, can be achieved by
exploiting covariate information. We apply the targeted maximum
likelihood methodology to the estimation of treatment specific
survival at a fixed end point for right-censored survival outcomes.
This approach provides a method for covariate adjustment, that under
no or uninformative censoring, does not require any additional
parametric modeling assumptions, and, under informative censoring, is
consistent under consistent estimation of the censoring mechanism or
the conditional hazard for survival. Thus, the targeted maximum
likelihood estimator has two important advantages over the
Kaplan-Meier estimator: 1) It exploits covariates to improve
efficiency, and 2) It is consistent in the presence of informative
censoring. These properties are demonstrated through simulation
studies. Extensions to the methodology are provided for non
randomized post-market safety studies and also for the inclusion of
time-dependent covariates.
- Subject Area:
- Clinical Trials
- Suggested Citation:
- Kelly L. Moore and Mark J. van der Laan,
"Application of Time-to-Event Methods in the Assessment of Safety in Clinical Trials"
(April 2009).
U.C. Berkeley Division of Biostatistics Working Paper Series.
Working Paper 248.
http://www.bepress.com/ucbbiostat/paper248